0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
Anthem Biosciences' Rs 3,395 crore IPO will test investor sentiment as Sensex and Nifty slide amid global trade tensions and domestic market volatility, offering a key barometer for biotech resilience in turbulent times.
Share this article
If you liked this article share it with your friends.they will thank you later
/tice-news-prod/media/media_files/2025/04/08/wvWOEK1LAJanixJ2etnt.png)
/tice-news-prod/media/media_files/2025/04/09/1WbAjeOhXIe0eJ7J83tH.png)
3 Min read
/tice-news-prod/media/media_files/2025/03/10/JTAMl75x7enD7b7VxCKk.png)
/tice-news-prod/media/media_files/M42vSZBO13MVZT8rPZJ6.jpg)
/tice-news-prod/media/media_files/TBQ8SIP138Pxvdhdb2h9.jpg)
/tice-news-prod/media/agency_attachments/EPJ25TmWqnDXQon5S3Mc.png)
